1-7 of 7
Syd Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Next-Generation Fc-Bearing CD3-Engaging Bispecific DART ® Platform with Extended Pharmacokinetic and Expanded Pharmacologic Window: Characterization As CD123 x CD3 and CD19 x CD3 DART Molecules

Ezio Bonvini, MD, Ross La Motte-Mohs, PhD, Ling Huang, Chia-Ying Kao Lam, PhD, Thomas Kaufman, Liqin Liu, PhD, Ralph F. Alderson, PhD, Kurt Stahl, Jennifer G. Brown, PhD, Hua Li, Sharad Sharma, PhD, James Tamura, PhD, Syd Johnson, PhD, Paul Moore, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5230.
https://doi.org/10.1182/blood-2018-99-116264
Published: 2018
Journal Articles

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

Muneera Al-Hussaini, Michael P. Rettig, Julie K. Ritchey, Darja Karpova, Geoffrey L. Uy, Linda G. Eissenberg, Feng Gao, William C. Eades, Ezio Bonvini, Gurunadh R. Chichili, Paul A. Moore, Syd Johnson, Lynne Collins, John F. DiPersio
Journal: Blood
Blood (2016) 127 (1): 122–131.
https://doi.org/10.1182/blood-2014-05-575704
Published: 2016
Includes: Supplemental data
Journal Articles

MGD011, Humanized CD19 x CD3 DART ® Protein with Enhanced Pharmacokinetic Properties, Demonstrates Potent T-Cell Mediated Anti-Tumor Activity in Preclinical Models and Durable B-Cell Depletion in Cynomolgus Monkeys Following Once-a-Week Dosing

Liqin Liu, PhD, Annie Lam, PhD, Ralph Alderson, PhD, Yinhua Yang, MD, Hua Li, M.S., Vatana Long, M.S., Sergey Gorlatov, PhD, Steve Burke, B.S., Valentina Ciccarone, PhD, Jeffrey Nordstrom, PhD, Syd Johnson, PhD, Paul Moore, PhD, Ezio Bonvini, MD
Journal: Blood
Blood (2014) 124 (21): 1775.
https://doi.org/10.1182/blood.V124.21.1775.1775
Published: 2014
Journal Articles

Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs ® )

Muneera H. AL Hussaini, MBBS, Julie Ritchey, Michael P. Rettig, PhD, Linda Eissenberg, PhD, Geoffrey L. Uy, MD, Gurunadh Chichili, PhD, Paul A Moore, PhD, Syd Johnson, PhD, Lynne Collins, Ezio Bonvini, John F. DiPersio, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 360.
https://doi.org/10.1182/blood.V122.21.360.360
Published: 2013
Journal Articles

Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

Paul A. Moore, Wenjun Zhang, G. Jonah Rainey, Steve Burke, Hua Li, Ling Huang, Sergey Gorlatov, Maria Concetta Veri, Sudeepta Aggarwal, Yinhua Yang, Kalpana Shah, Linda Jin, Sunan Zhang, Leilei He, Tengfei Zhang, Valentina Ciccarone, Scott Koenig, Ezio Bonvini, Syd Johnson
Journal: Blood
Blood (2011) 117 (17): 4542–4551.
https://doi.org/10.1182/blood-2010-09-306449
Published: 2011
Includes: Supplemental data
Journal Articles

An Fc-Optimized Monoclonal Antibody Against CD32B, the Human Inhibitory Fc- γ Receptor IIB, in the Immunotherapy of B-Cell Malignanacy.

Jeffrey B. Stavenhagen, PhD, Sergey Gorlatov, Ph.D., Nadine Tuaillon, Ph.D., Christopher T. Rankin, Ph.D., Maria-Concetta Veri, Ph.D., David Inzunza, M.D., Stephen Burke, Ling Huang, Hua Li, Shannon Thomas, Syd Johnson, Ph.D., Jeffrey Ravetch, M.D., Ph.D., Scott Koenig, M.D., Ph.D., Ezio Bonvini, MD
Journal: Blood
Blood (2006) 108 (11): 2529.
https://doi.org/10.1182/blood.V108.11.2529.2529
Published: 2006
Journal Articles

CD32B, the human inhibitory Fc-γ receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma

Christopher T. Rankin, Maria-Concetta Veri, Sergey Gorlatov, Nadine Tuaillon, Steve Burke, Ling Huang, H. David Inzunza, Hua Li, Shannon Thomas, Syd Johnson, Jeffrey Stavenhagen, Scott Koenig, Ezio Bonvini
Journal: Blood
Blood (2006) 108 (7): 2384–2391.
https://doi.org/10.1182/blood-2006-05-020602
Published: 2006
Includes: Supplemental data